Cystic fibrosis: A new mutation in the Lebanese population

Slides:



Advertisements
Similar presentations
Wilson disease as a cause of liver injury in cystic fibrosis
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Treatment compliance in children and adults with Cystic Fibrosis
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Mutational spectrum of cystic fibrosis in the Lebanese population
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
The ease of breathing test tracks clinical changes in cystic fibrosis
Controlled clinical trials in cystic fibrosis — are we doing better?
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time  Rosemary Ball, Kevin W. Southern, Pamela.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c G>A  Aleksandra Nikolic, Nedeljko Radlovic,
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis  Donna Drury, Vijay Laxmi Grey, Guylaine Ferland, Caren Gundberg,
A.H. Gifford  Journal of Cystic Fibrosis 
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Wilson disease as a cause of liver injury in cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS  Dorota Sands, Ewa Sapiejka, Grzegorz.
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
B. M. Ciminelli, A. Bonizzato, C. Bombieri, F. Pompei, M. Gabaldo, C
L. Uppaluri, S.J. England, T.F. Scanlin  Journal of Cystic Fibrosis 
V. Terlizzi, A. Tosco, R. Tomaiuolo, A. Sepe, N. Amato, A. Casale, C
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
Gut dysbiosis in cystic fibrosis
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Absence of a gender gap in survival
Presentation transcript:

Cystic fibrosis: A new mutation in the Lebanese population Chantal Farra, Rita Medawar, Salman Mroueh, Myrna Souaid, Faiza Cabet, Johnny Awwad  Journal of Cystic Fibrosis  Volume 7, Issue 5, Pages 429-432 (September 2008) DOI: 10.1016/j.jcf.2008.03.003 Copyright © 2008 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Sequence analysis of the 4016insG (exon 21) mutation in one of our homozygous patients (top) and in one of his heterozygous parents (middle). Wild-type sequence for comparison is shown in the bottom. In the homozygous individual, we can clearly see insertion of G followed by the T repeat. In the heterozygous individual, the 4016insG produces an overlap between the wild-type allele and the mutated allele. Journal of Cystic Fibrosis 2008 7, 429-432DOI: (10.1016/j.jcf.2008.03.003) Copyright © 2008 European Cystic Fibrosis Society Terms and Conditions